Czechs promise action over incontinence aids:
This article was originally published in Clinica
Executive Summary
Czech Health Minister Bohumil Fiser has reassured the European medical device industry that the Czech authorities will look into alleged arbitrary reimbursement listing practices for medical incontinence aids. During a meeting on July 17, Michael Baker, director general of the medical device industry association, EUCOMED, told Mr Fiser that companies present on the Czech market had encountered difficulties in obtaining reimbursement by local sickness funds, placing them at a competitive disadvantage. Mr Baker believes there is now "willingness on the Czech side to take early action to resolve current difficulties".
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.
Novartis Hires Ex-BMS Chief As It Pursues US Growth Strategy
The Swiss pharma company is looking to tap into the experience of ex-BMS leader Giovanni Caforio to help further it US-first commercial strategy.